SHL Telemedicine Ltd American Depositary Shares
SHLT
SHLT was delisted on the 2nd of April, 2025.
5 hedge funds and large institutions have $9.91M invested in SHL Telemedicine Ltd American Depositary Shares in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
67% more funds holding
Funds holding: 3 → 5 (+2)
11% more capital invested
Capital invested by funds: $8.96M → $9.91M (+$949K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YDMI
Y.D. More Investments
Ramat Gan,
Israel
|
-$431K |
SHLT Hedge Fund Activity: Q4 2024 in Review
5 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in SHL Telemedicine Ltd American Depositary Shares (SHLT) for Q4 2024, worth a combined $9.91M — up 11% from $8.96M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new SHLT positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $12K. The largest seller was Y.D. More Investments, cutting an estimated $431K.
- 5 institutional investors held SHL Telemedicine Ltd American Depositary Shares (SHLT) as of Q4 2024, up from 3 in Q3 2024.
- Funds reported $9.91M of SHL Telemedicine Ltd American Depositary Shares stock for Q4 2024, up 11% quarter-over-quarter.
- 2 funds opened new SHL Telemedicine Ltd American Depositary Shares positions in Q4 2024 and 0 closed out, a net change of +2 holders.
- The largest SHL Telemedicine Ltd American Depositary Shares buyer in Q4 2024 was UBS Group, an estimated $12K added.
- The largest SHL Telemedicine Ltd American Depositary Shares seller in Q4 2024 was Y.D. More Investments, an estimated $431K sold.
Based on aggregated 13F filings for Q4 2024.